CN1853654B - 一种含有珍珠和维生素的口服制剂 - Google Patents
一种含有珍珠和维生素的口服制剂 Download PDFInfo
- Publication number
- CN1853654B CN1853654B CN200510049711A CN200510049711A CN1853654B CN 1853654 B CN1853654 B CN 1853654B CN 200510049711 A CN200510049711 A CN 200510049711A CN 200510049711 A CN200510049711 A CN 200510049711A CN 1853654 B CN1853654 B CN 1853654B
- Authority
- CN
- China
- Prior art keywords
- vitamin
- margarita
- oral formulations
- silica gel
- lactose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000011782 vitamin Substances 0.000 title claims abstract description 40
- 238000002360 preparation method Methods 0.000 title description 4
- WIGIZIANZCJQQY-UHFFFAOYSA-N 4-ethyl-3-methyl-N-[2-[4-[[[(4-methylcyclohexyl)amino]-oxomethyl]sulfamoyl]phenyl]ethyl]-5-oxo-2H-pyrrole-1-carboxamide Chemical compound O=C1C(CC)=C(C)CN1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCC(C)CC2)C=C1 WIGIZIANZCJQQY-UHFFFAOYSA-N 0.000 title 1
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims abstract description 62
- 239000000843 powder Substances 0.000 claims abstract description 41
- 229940088594 vitamin Drugs 0.000 claims abstract description 39
- 229930003231 vitamin Natural products 0.000 claims abstract description 39
- 235000013343 vitamin Nutrition 0.000 claims abstract description 39
- 239000011790 ferrous sulphate Substances 0.000 claims abstract description 32
- 235000003891 ferrous sulphate Nutrition 0.000 claims abstract description 32
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 claims abstract description 32
- 229910000359 iron(II) sulfate Inorganic materials 0.000 claims abstract description 32
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 claims abstract description 32
- 229960001763 zinc sulfate Drugs 0.000 claims abstract description 32
- 229910000368 zinc sulfate Inorganic materials 0.000 claims abstract description 32
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims abstract description 31
- 235000019359 magnesium stearate Nutrition 0.000 claims abstract description 31
- 239000000741 silica gel Substances 0.000 claims abstract description 31
- 229910002027 silica gel Inorganic materials 0.000 claims abstract description 31
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims abstract description 29
- 239000008101 lactose Substances 0.000 claims abstract description 29
- 235000005956 Cosmos caudatus Nutrition 0.000 claims description 92
- 244000293323 Cosmos caudatus Species 0.000 claims description 92
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 68
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 64
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 34
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 34
- 229930003427 Vitamin E Natural products 0.000 claims description 34
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 34
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 34
- 235000019155 vitamin A Nutrition 0.000 claims description 34
- 239000011719 vitamin A Substances 0.000 claims description 34
- 235000019165 vitamin E Nutrition 0.000 claims description 34
- 239000011709 vitamin E Substances 0.000 claims description 34
- 229940046009 vitamin E Drugs 0.000 claims description 34
- 229940045997 vitamin a Drugs 0.000 claims description 34
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 32
- 229930003268 Vitamin C Natural products 0.000 claims description 32
- -1 hydroxypropyl Chemical group 0.000 claims description 32
- 239000000203 mixture Substances 0.000 claims description 32
- 235000019154 vitamin C Nutrition 0.000 claims description 32
- 239000011718 vitamin C Substances 0.000 claims description 32
- 101800002326 Adipokinetic hormone Proteins 0.000 claims description 31
- 229930003316 Vitamin D Natural products 0.000 claims description 31
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 31
- 235000019166 vitamin D Nutrition 0.000 claims description 31
- 239000011710 vitamin D Substances 0.000 claims description 31
- 150000003710 vitamin D derivatives Chemical class 0.000 claims description 31
- 229940046008 vitamin d Drugs 0.000 claims description 31
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 28
- 238000009472 formulation Methods 0.000 claims description 24
- 239000003826 tablet Substances 0.000 claims description 18
- 239000002775 capsule Substances 0.000 claims description 10
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 8
- 239000000600 sorbitol Substances 0.000 claims description 8
- 239000007910 chewable tablet Substances 0.000 claims description 4
- 229940068682 chewable tablet Drugs 0.000 claims description 4
- 239000002552 dosage form Substances 0.000 claims description 2
- 239000007935 oral tablet Substances 0.000 claims description 2
- 229940096978 oral tablet Drugs 0.000 claims description 2
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 abstract description 15
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 abstract description 15
- 208000001132 Osteoporosis Diseases 0.000 abstract description 6
- 239000003814 drug Substances 0.000 abstract description 6
- 238000007254 oxidation reaction Methods 0.000 abstract description 4
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 abstract 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 abstract 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 abstract 1
- 229960001231 choline Drugs 0.000 abstract 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 abstract 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 abstract 1
- 230000001502 supplementing effect Effects 0.000 abstract 1
- 239000008187 granular material Substances 0.000 description 36
- 239000011575 calcium Substances 0.000 description 18
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 17
- 229910052791 calcium Inorganic materials 0.000 description 16
- 241000700159 Rattus Species 0.000 description 15
- 206010013786 Dry skin Diseases 0.000 description 14
- 238000001035 drying Methods 0.000 description 14
- 238000002156 mixing Methods 0.000 description 14
- 239000007779 soft material Substances 0.000 description 14
- 230000000694 effects Effects 0.000 description 11
- 210000000689 upper leg Anatomy 0.000 description 10
- 230000003203 everyday effect Effects 0.000 description 9
- 238000002474 experimental method Methods 0.000 description 5
- 230000002265 prevention Effects 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 235000021590 normal diet Nutrition 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 102000003992 Peroxidases Human genes 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 238000001739 density measurement Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 230000037356 lipid metabolism Effects 0.000 description 2
- 239000002398 materia medica Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000008558 metabolic pathway by substance Effects 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 108040007629 peroxidase activity proteins Proteins 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- 102000016893 Amine Oxidase (Copper-Containing) Human genes 0.000 description 1
- 108010028700 Amine Oxidase (Copper-Containing) Proteins 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 102000018832 Cytochromes Human genes 0.000 description 1
- 108010052832 Cytochromes Proteins 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 241000201295 Euphrasia Species 0.000 description 1
- WSMYVTOQOOLQHP-UHFFFAOYSA-N Malondialdehyde Chemical compound O=CCC=O WSMYVTOQOOLQHP-UHFFFAOYSA-N 0.000 description 1
- 102000036675 Myoglobin Human genes 0.000 description 1
- 108010062374 Myoglobin Proteins 0.000 description 1
- BAWFJGJZGIEFAR-NNYOXOHSSA-N NAD zwitterion Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-N 0.000 description 1
- 241000475481 Nebula Species 0.000 description 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical class [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 210000000709 aorta Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000037182 bone density Effects 0.000 description 1
- 150000001669 calcium Chemical class 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 230000004098 cellular respiration Effects 0.000 description 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N ferric oxide Chemical compound O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 1
- 235000003969 glutathione Nutrition 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000003212 lipotrophic effect Effects 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 229950006238 nadide Drugs 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 210000002706 plastid Anatomy 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 150000004032 porphyrins Chemical class 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019160 vitamin B3 Nutrition 0.000 description 1
- 239000011708 vitamin B3 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
组别 | 数量 | BMD(g/cm<sup>2</sup>) |
1 | 10 | 0.0986±0.0005* |
2 | 10 | 0.1321±0.0004* |
3 | 10 | 0.1719±0.0005** |
组别 | 数量 | Ca(mg/g) |
1 | 10 | 96.5±0.36* |
2 | 10 | 115.5±0.61* |
3 | 10 | 151.4±0.68** |
组别 | 数量 | SOD(UN/ml) | MDA(nmol/ml) | GSH-Px |
1 | 10 | 112.5±0.6* | 12.5±0.5* | 140±3.5* |
2 | 10 | 82.3±0.5* | 7.6±0.4* | 125±4.3* |
3 | 10 | 88.4±0.6* | 8.3±0.4* | 130±1.8* |
4 | 10 | 93.4±0.6* | 6.4±0.3* | 119±2.9* |
5 | 10 | 70.1±0.6** | 4.3±0.3** | 116±3.9** |
组别 | 数量 | BMD(g/cm<sup>2</sup>) |
高含量组 | 10 | 0.1285±0.0402* |
中含量组 | 10 | 0.1716±0.0010** |
低含量组 | 10 | 0.1319±0.0006* |
纯珍珠组 | 10 | 0.1221±0.0038* |
空白组 | 10 | 0.0959±0.0042* |
组别 | 数量 | Ca(mg/g) |
高含量组 | 10 | 120.46±0.52* |
中含量组 | 10 | 156.27±0.18** |
低含量组 | 10 | 114.09±0.24* |
纯珍珠组 | 10 | 117.32±0.39* |
空白组 | 10 | 97.47±0.28* |
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200510049711A CN1853654B (zh) | 2005-04-29 | 2005-04-29 | 一种含有珍珠和维生素的口服制剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200510049711A CN1853654B (zh) | 2005-04-29 | 2005-04-29 | 一种含有珍珠和维生素的口服制剂 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1853654A CN1853654A (zh) | 2006-11-01 |
CN1853654B true CN1853654B (zh) | 2010-05-26 |
Family
ID=37194308
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200510049711A Expired - Fee Related CN1853654B (zh) | 2005-04-29 | 2005-04-29 | 一种含有珍珠和维生素的口服制剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1853654B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102824368B (zh) * | 2012-09-03 | 2014-11-05 | 孙培雄 | 一种珍珠维生素c片剂及其制作方法 |
CN104489830B (zh) * | 2014-11-28 | 2016-06-01 | 东莞市莞信企业管理咨询有限公司 | 一种用于防治口腔溃疡的营养液 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1261535A (zh) * | 1999-01-18 | 2000-08-02 | 倪荣聪 | 蛋氨酸组合物在制备治疗心、脑血管疾病的药物中的应用 |
CN1335138A (zh) * | 2000-07-21 | 2002-02-13 | 北京本元青阳生物科技发展有限公司 | 含珍珠粉和抗坏血酸的组合物 |
CN1350850A (zh) * | 2000-10-31 | 2002-05-29 | 上海市药材有限公司中药制药一厂 | 一种复方超细珍珠粉软胶囊及制备方法 |
CN1436539A (zh) * | 2002-02-06 | 2003-08-20 | 李福康 | 高效铁锌钙补血补钙保健品及其制备方法 |
-
2005
- 2005-04-29 CN CN200510049711A patent/CN1853654B/zh not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1261535A (zh) * | 1999-01-18 | 2000-08-02 | 倪荣聪 | 蛋氨酸组合物在制备治疗心、脑血管疾病的药物中的应用 |
CN1335138A (zh) * | 2000-07-21 | 2002-02-13 | 北京本元青阳生物科技发展有限公司 | 含珍珠粉和抗坏血酸的组合物 |
CN1350850A (zh) * | 2000-10-31 | 2002-05-29 | 上海市药材有限公司中药制药一厂 | 一种复方超细珍珠粉软胶囊及制备方法 |
CN1436539A (zh) * | 2002-02-06 | 2003-08-20 | 李福康 | 高效铁锌钙补血补钙保健品及其制备方法 |
Non-Patent Citations (1)
Title |
---|
JP特开2003-292447A 2003.10.15 |
Also Published As
Publication number | Publication date |
---|---|
CN1853654A (zh) | 2006-11-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1216024B1 (en) | Formulation for menopausal women | |
CN102150861B (zh) | 一种具有抗氧化、抗疲劳功能的营养补充剂 | |
EP3435788B1 (en) | Bilayer tablets of vitamin | |
CN102048884B (zh) | 一种含瓜拉那提取物的减肥组合物 | |
DE60008276T2 (de) | Magensaftresistente tablette für nahrung, diät und therapie | |
CN100418548C (zh) | 一种药用组合物及其用途 | |
CN1853654B (zh) | 一种含有珍珠和维生素的口服制剂 | |
CN103005435B (zh) | 一种抗疲劳、提高速度耐力的组合物及含其制剂 | |
CN105433382B (zh) | 一种玛咖组合物及其制备方法和用途 | |
CN105815770A (zh) | 不具有大剂量的营养补充剂的副作用的多种维生素/矿物质制剂 | |
CN101574145A (zh) | 一种营养强化补剂 | |
CN101156862B (zh) | 一种卵磷脂维生素e咀嚼片及其制备方法 | |
CN100553644C (zh) | 一种含有珍珠和维生素的组合物及其应用 | |
CN101112466B (zh) | 一种治疗黄褐斑和通便的复方组合物及其应用 | |
CN107136490A (zh) | 一种肽虫草保健品 | |
CN109496154A (zh) | 一种nadh复方组合物及其制剂和应用 | |
FR2838645A1 (fr) | Nouvelles compositions synergiques de vitamines, de mineraux et d'oligo-elements pour stimuler l'elimination des lipides intracellulaires | |
CN108159073A (zh) | 一种碳酸钙胶囊 | |
RU2275192C2 (ru) | Витаминно-минеральный комплекс | |
RU2323599C1 (ru) | Биологически активная добавка к пище и способ ее получения | |
CN109418804A (zh) | 一种海藻咀嚼片及其制备方法 | |
RU2282442C2 (ru) | Комбинированный поливитаминный состав и способ его получения | |
CN110367523A (zh) | 同步补充vd、vk的孕妇乳母膳食营养补充片剂 | |
DE102022004360A1 (de) | Mikronährstoff-enthaltendes Produkt zur Nahrungsergänzung | |
AU2005200907B2 (en) | Formulation for menopausal women |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP01 | Change in the name or title of a patent holder |
Address after: 311804 Zhejiang, Zhuji City Industrial Park under the lake Patentee after: PURE PEARL GROUP Co.,Ltd. Address before: 311804 Zhejiang, Zhuji City Industrial Park under the lake Patentee before: Zhejiang Shanxiahu Pearl Group Co.,Ltd. |
|
CP01 | Change in the name or title of a patent holder | ||
CP03 | Change of name, title or address |
Address after: Hu Zhen Zheng Jia Hu Cun 311804 Zhejiang city of Zhuji Province under the mountain Patentee after: Innovative healthcare management Limited by Share Ltd. Address before: 311804 Zhejiang, Zhuji City Industrial Park under the lake Patentee before: PURE PEARL GROUP Co.,Ltd. |
|
CP03 | Change of name, title or address | ||
TR01 | Transfer of patent right |
Effective date of registration: 20170309 Address after: 311804 Zhejiang city of Zhuji Province Pearl Characteristic Industrial Park Patentee after: Zhejiang Yinggelai Pharmacy Co.,Ltd. Address before: Hu Zhen Zheng Jia Hu Cun 311804 Zhejiang city of Zhuji Province under the mountain Patentee before: Innovative healthcare management Limited by Share Ltd. |
|
TR01 | Transfer of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20100526 Termination date: 20180429 |
|
CF01 | Termination of patent right due to non-payment of annual fee |